Scientific Excellence in Preclinical Ocular Models
At Experimentica, we combine our expertise in Ophthalmology and preclinical ocular models with state of the art imaging, AI, and functional assessment capabilities.
A global CRO, we work with Pharmaceutical Companies, Biotechs, and Academia. We work to prevent and cure ophthalmic conditions by supporting our customers to develop innovative treatments where unmet medical needs remain.
We offer a preclinical development pipeline with an industry-leading portfolio of in vitro, ex vivo and in vivo models in rodents and larger animals, such as:
- Dry Eye Disease (DED)
- Age-related Macular Disease (AMD)
- Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
- Glaucoma
- Retinitis pigmentosa (RP)
- Retinopathy of prematurity (ROP)
- Other indications in Inflammation, Ischemia, and Neuroprotection: Optic Neuritis, Retinal Ischemia, Multiple Sclerosis, Stroke
- Species: Mouse, Rat, Rabbit, Minipig, and NHP (through a partnership).
We also provide custom models and GLP-like tolerability, toxicity, PK and PD ocular studies.
The company is headquartered in Finland, with labs in Finland, Lithuania, and the U.S. (Texas, Illinois).